Navigation Links
OncoSec and Serametrix Collaborate to Identify Potential Biomarkers to Enhance Skin Cancer Immune Therapies
Date:11/16/2011

provide a more rational approach to patient treatment.

About OncoSec Medical Inc.

OncoSec Medical Incorporated (OTCBB: ONCS) develops novel OMS ElectroOncology therapies that combine its proprietary electroporation delivery technology with a chemotherapeutic or novel DNA-based immunotherapeutics. Targeted local delivery of these agents is designed to achieve selective destruction of cancerous tumors while sparing healthy normal tissue, resulting in improved functional, cosmetic and quality of life outcomes. These therapies have achieved validating safety and efficacy data in early and late stage clinical studies of over 400 cancer patients. OncoSec's clinical programs include three Phase II clinical trials for OMS ElectroImmunotherapy™. More information is available at www.oncosec.com. Additional information may also be found at OncoSec's Facebook, Twitter, and LinkedIn sites.

This press release contains forward looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Any statements in this release that are not historical facts may be considered such "forward looking statements." Forward looking statements are based on management's current preliminary expectations and are subject to risks and uncertainties which may cause our results to differ materially and adversely from the statements contained herein. Some of the potential risks and uncertainties that could cause actual results to differ from those predicted include our ability to raise additional funding, our ability to acquire, develop or commercialize new products, uncertainties inherent in pre-clinical studies and clinical trials, unexpected new data, safety and technical issues, competition and market con
'/>"/>

SOURCE OncoSec Medical Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. OncoSec Medical Licenses Non-DNA Vaccine Tumor Therapy Technology from Inovio Pharmaceuticals
2. Inovio Pharmaceuticals Licenses Non-DNA Vaccine Tumor Therapy Technology to OncoSec Medical
3. OncoSec Medical to Present at ROTH 23rd Annual Growth Stock Conference
4. OncoSec Medical Closes $1.1M Financing
5. OncoSec Medical Closes Purchase and License Agreement for Tumor Therapy Technology with Inovio Pharmaceuticals
6. OncoSec Medical Announces the Appointment of Dr. Anthony E. Maida, III, to Its Board of Directors
7. OncoSec Medical Appoints Engineering Leader
8. OncoSec Medical to Present at Industry and Investor Conferences
9. OncoSec Medical to Attend 6th Annual Fire, Ice and Beyond: The Future of Ablation Therapies Conference
10. OncoSec Announces Positive Results from Head & Neck and Breast Cancer Trials
11. Update: OncoSec Announces Positive Results From Head & Neck and Breast Cancer Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... Calif. , May 28, 2015  Based ... market, Frost & Sullivan recognizes Lexmark Healthcare ... Sullivan Award for Company of the Year in ... take HCM to the next level of interoperability ... acquisitions and followed them up with large-scale product ...
(Date:5/28/2015)... SAN DIEGO , May 28, 2015 ... company, and the Clinic for Special Children today announced ... will be utilized for the diagnosis of rare genetic ... Strasburg, Pennsylvania , the Clinic for Special Children ... population with a relatively high incidence of genetic disease. ...
(Date:5/28/2015)... , May 28, 2015  Freedom Meditech, Inc., a ... chronic diseases from current blood-based standards to early and ... $4.8 million in a Series C financing. The company ... $14 million since founded. The company has also appointed ... and a member of the company,s board of directors. ...
Breaking Medicine Technology:Frost & Sullivan Acknowledges Lexmark Healthcare's Energy, Creativity, and Diligence in Developing the Leading Next-Generation Healthcare Content Management Platform 2Frost & Sullivan Acknowledges Lexmark Healthcare's Energy, Creativity, and Diligence in Developing the Leading Next-Generation Healthcare Content Management Platform 3Frost & Sullivan Acknowledges Lexmark Healthcare's Energy, Creativity, and Diligence in Developing the Leading Next-Generation Healthcare Content Management Platform 4Frost & Sullivan Acknowledges Lexmark Healthcare's Energy, Creativity, and Diligence in Developing the Leading Next-Generation Healthcare Content Management Platform 5Cypher Genomics and Clinic for Special Children Collaborate on Rare Disease Study 2Cypher Genomics and Clinic for Special Children Collaborate on Rare Disease Study 3Freedom Meditech Raises $4.8 Million and Appoints John Gerace as Chief Executive Officer 2Freedom Meditech Raises $4.8 Million and Appoints John Gerace as Chief Executive Officer 3Freedom Meditech Raises $4.8 Million and Appoints John Gerace as Chief Executive Officer 4
... 2010 Biovista,announced today the appointment of Mr. Clifford H. Farrah ... , , ... to have Cliff join our Advisory Board," said Aris,Persidis, President of Biovista. "Cliff ... that will be,invaluable to us as we grow Biovista," he added. , ...
... AGAWAM, Mass. , July 13 A new free, ... of applying new U.S. Food and Drug Administration (FDA) regulations to ... from Microtest Laboratories ( http://www.microtestlabs.com/combination-products-20/ ) , ... Combination products are a large and growing ...
Cached Medicine Technology:Biovista Announces the Appointment of Clifford H. Farrah to its Advisory Board 2New White Paper Helps Medical Device Manufacturers Apply New FDA Regs to Combination Products 2New White Paper Helps Medical Device Manufacturers Apply New FDA Regs to Combination Products 3New White Paper Helps Medical Device Manufacturers Apply New FDA Regs to Combination Products 4
(Date:5/27/2015)... May 28, 2015 Calls Upon Individuals, Organizations ... A new nationwide initiative – a “Summer of Service” – ... and build partnerships to grow the number of individuals and ... its commitment to Veterans by inviting the community to visit ... June 29, 2015 from 1 – 3:00 p.m. in the ...
(Date:5/27/2015)... San Rafael, CA (PRWEB) May 27, 2015 ... Softball Camp director, Bree Nasti, the Adelphi University softball ... to the Divsion II Softball Championship since becoming a ... at 0-11, Adelphi University softball team turned it around ... Softball Championship. After defeating University of Central Missouri in ...
(Date:5/27/2015)... Down is a reputable source of 2015 NHL Western Conference ... middle of their series against the Anaheim Ducks with the Ducks ... can win tonight at home, this will tie up the series ... Honda Center in Anaheim. , During the regular season, the ... they won the Pacific Division by 8 points ahead of the ...
(Date:5/27/2015)... As the U.S. Supreme Court considers the ... the Affordable Care Act (ACA), an investigation by the ... RAND Corporation and Express Scripts provides an unprecedented look ... enrollees. , The analysis is published online as ... also appear in the journal’s June issue. , The ...
(Date:5/27/2015)... 2015 Khanna Vision Institute (KVI) announced the ... focussed on keratoconus eye disease . Keratoconus is commonly ... its onset in the teenage years. It worsens over the ... front clear part of the eye is defective. It becomes ... It results in poor vision which cannot even be corrected ...
Breaking Medicine News(10 mins):Health News:VA Begins “Summer of Service” to Bolster Volunteer Assistance for Veterans 2Health News:VA Begins “Summer of Service” to Bolster Volunteer Assistance for Veterans 3Health News:US Sports Camps and Nike Softball Camps Congratulate the Adelphi University Softball Team 2Health News:Blackhawks vs. Ducks NHL Western Conference Finals Tickets: Ticket Down Slashes Ticket Prices on Chicago Blackhawks vs. Anaheim Ducks 2015 NHL Western Conference Finals 2Health News:Large-Scale Analysis of Medication Data Provides Insights into Who Is Covered by Affordable Care Act 2Health News:Large-Scale Analysis of Medication Data Provides Insights into Who Is Covered by Affordable Care Act 3Health News:Large-Scale Analysis of Medication Data Provides Insights into Who Is Covered by Affordable Care Act 4Health News:KVI announced the launch of The Keratoconus website focused on age based keratoconus treatment . 2
... (HealthDay News) -- Hormone levels at certain phases of the ... Researchers used MRI to study the brains of women ... pleasant, unpleasant or neutral. This test was repeated at different ... follicular stage of the menstrual cycle, no areas of the ...
... Reporter , TUESDAY, Oct. 26 (HealthDay News) -- Dr. Alexander Heazell ... their first child in 2001. They planned to name him Jack. ... wife,s blood pressure had shot up during the pregnancy, and at ... Losing the baby was devastating for Heazell and his wife. The ...
... and biologist Professor Cesare Montecucco, 62, of the Department ... has won the 100,000 euro Paul Ehrlich and Ludwig ... the field of bacterial diseases, including tetanus, botulism, anthrax ... by the Scientific Board of the Paul Ehrlich Foundation. ...
... scar tissue surrounding cancer tumours aims to provide new targets for ... deaths in the UK. Funded by the UK charity Pancreatic ... family of molecules present in this scar tissue - known as ... tumour growth. The project is led by surgeon and ...
... are common among the caregivers of children with a ... of a small study from the Johns Hopkins Children Center. ... researchers add. The study,s findings, published online in ... healthcare staff to do a better job in educating parents, ...
... (HealthDay News) -- Having a prostate-specific antigen (PSA) test to ... develops it will spread to other parts of the body, ... debate on whether PSA screenings actually improve survival rates or, ... that routine screening not only improves the patient,s quality of ...
Cached Medicine News:Health News:Stillbirth Can Be Devastating, Unpredictable 2Health News:Stillbirth Can Be Devastating, Unpredictable 3Health News:Professor Cesare Montecucco to receive the 2011 Paul Ehrlich and Ludwig Darmstaedter Prize 2Health News:Stroma may provide key to better cancer treatment 2Health News:Knowledge gaps, fears common among parents of children with drug-resistant bacteria 2Health News:Knowledge gaps, fears common among parents of children with drug-resistant bacteria 3Health News:PSA Test Reduces Risk of Spread if Prostate Cancer Strikes 2Health News:PSA Test Reduces Risk of Spread if Prostate Cancer Strikes 3
Sinskey lens manipulator, straight. Also available in titanium....
ICL manipulator with textured micro-ball tip....
... Keeler ophthalmoscopes are individually adjusted for perfect ... eye, not on paper. This, along with ... focus, ensures that whatever the patient's pupil ... largest field of view. Lithium-ion technology provides ...
The Beta 200S combines Heine's patented aspherical optics (U.S. Pat. 4.963.014) and a single-step Rekoss disk with a range of 36 to +38 dpt. to provide perfectly-focused images even in cases of high ...
Medicine Products: